[1] [2] The severity varies considerably between individuals and is generally dose-dependenthigher doses tend to produce more pronounced gastrointestinal effects
ArticlePubMed 48
Results vary by treatment type, patient health, age, skin quality, adherence, medications, and treatment plan
Option 4: combination approach The ATTAIN-MAINTAIN trial data suggests a compelling combination strategy: use injectable tirzepatide to achieve aggressive initial weight loss, then transition to oral orforglipron (once available) for convenient long-term maintenance
Its principal physiological role is to transport long-chain fatty acids into the mitochondria the energy-producing structures within cells where they are broken down to generate energy
POPULATION TESTING There is insufficient evidence associating GSTM1 , GSTT1 , or GSTP1 with ovarian cancer for population testing to be considered